Search company, investor...
Search
Kumovis company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

kumovis.com

Founded Year

2017

Stage

Acquired | Acquired

Total Raised

$3.97M

About Kumovis

Kumovis develops 3D printers that are specifically tailored to medical device requirements, such as making skull plate or spinal implants.On February 23rd, 2022, Kumovis was acquired by 3D Systems. The terms of the transaction were not disclosed.

Kumovis Headquarters Location

Trimburgstrasse 2

Munich, 81249,

Germany

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kumovis

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kumovis is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,729 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Kumovis Patents

Kumovis has filed 4 patents.

The 3 most popular patent topics include:

  • 3D printers
  • 3D printing
  • Fused filament fabrication
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/27/2020

Fused filament fabrication, 3D printing, Manufacturing, Production and manufacturing, 3D printers

Application

Application Date

7/27/2020

Grant Date

Title

Related Topics

Fused filament fabrication, 3D printing, Manufacturing, Production and manufacturing, 3D printers

Status

Application

Latest Kumovis News

3D Printing Is Ready To Tackle Plastic Body Implants

Mar 31, 2022

Kumovis After an accident left a 40-year-old woman in Sweden with a massive head injury late last year, she received a 3D-printed implant made from a plastic called PEEK to repair her skull. It was the first time a hospital had designed and 3D printed an implant of this kind on-site, and it could prove a turning point for 3D printing in medical care. “As far as we know, we are the world’s first to make 3D implants entirely in a hospital, which means that the implants will be better adapted to the patients, right from the start," says Einar Heiberg Brandt, medical engineer in Clinical Physiology at Skåne University Hospital, Sweden. "This will lead to faster surgeries and fewer complications." In-hospital 3D printing is still in the early stages, but shows great promise, industry experts agree. Although 3D printing has been used in healthcare for more than a decade to manufacture titanium and stainless steel implants, PEEK plastic expands opportunities for the technology to move off the shop floors of medical device manufacturers and into labs at hospitals and clinics worldwide. In fact, medical facilities represent a vast new market for 3D printing. The healthcare segment of the 3D printing industry, which includes dental and 3D-printed pharmaceuticals, currently is valued at nearly $3 billion. 3D Printing at Hospitals Institutions, such as the Mayo Clinic in Minn. and VA hospitals nationwide, have extensive 3D printing labs. The work there is mostly patient-specific 3D-printed medical models , surgical training tools, and orthopedic braces. However, in the not too distant future, these hospitals may be 3D printing patient-specific implants in PEEK for all types of surgeries. MORE FOR YOU Kumovis Using a 3D printer and PEEK filament brings a long list of benefits to hospitals, while still having substantial hurdles. The method, when compared to traditional ways medical devices are made, namely machining and injection molding, can be done on-site at the point of care. This means faster implants, lower costs, and closer coordination between the surgeon and the technicians producing the implant. By using the patient's data from scans and X-rays, hospitals can 3D print a custom implant that fits precisely into the defect space. Studies show that patient-specific implants shorten surgery time, lower risks of infection, result in better outcomes, and dramatically reduce the length of a hospital stay. 3D printing the implants as needed also relieves the hospital from having to keep an inventory of expensive implants on hand. Although, as of today, there are no 3D-printed PEEK implants manufactured at hospitals approved by the FDA, that may soon change. A German start-up specializing in 3D-printed PEEK skull implants, Kumovis , says it’s completing the final hurdles in the FDA approval process. "There's a lot of excitement around 3D printing on-site at hospitals and the projects that are driving manufacturing at the point of care and showing what is possible," says Miriam Haerst, co-founder and co-CEO of Kumovis. South Carolina-based 3D Systems , one of the oldest and largest 3D printer manufacturers in the world, recently announced its plans to acquire Kumovis in order to expand from metal implants to PEEK implants at the point of care. “As [3D printing] technology becomes more user-friendly for medical professionals, more hospitals will be able to implement end-to-end solutions for personalized surgery,” says Gautam Gupta, vice president and general manager of 3D Systems medical devices practice. “This will disrupt existing healthcare models, improve the quality of care, and crucially, save more lives.” The Kumovis acquisition fits nicely into 3D Systems' established healthcare business and adds a new focus on decentralizing the production of medical implants. “Shifting the manufacturing to the hospitals will be a game-changer when it comes to the availability of implants,” says Haerst. For hospitals to become manufacturers, however, requires technical and engineering staff, regulatory processes, along with equipment. This could be managed on-site in a cooperative agreement by current medical device manufacturers, Haerst says. PEEK Plastic vs. Titanium for Implants PEEK has had FDA approval as an implant material for years when machined, but not yet when 3D printed. Although PEEK is used in numerous implants on the market today from spinal cages to ankle joints, 3D-printed PEEK still has to prove it has the same weight bearing and wear attributes as milled or molded PEEK. German materials manufacturer Evonik produces an implant grade, 3D printing filament, VESTAKEEP i4 ... [+]4 G, that can be used in permanent medical implants. Evonik Overall, this bio-compatible material has several perceived advantages over stainless steel and titanium: it's lightweight, permeable to ultrasound, and practically invisible to CT and MRI scans enabling better post-op monitoring. Over the years 3D-printed titanium gained a reputation for better bone integration and thousands of joint and spine implants are 3D printed every year by major manufacturers, such as Stryker. But PEEK has changed, says Marc Knebel, head of medical systems at Evonik , which manufactures PEEK for 3D printing as well as injection molding and milling. "Today, PEEK can be designed with additives to gain new features, such as better osteointegration," says Knebel. "We are working with a couple of hospitals on [3D-printed implants] already. The first ones will be active within the next five years." A 3D printing lab situated next to the operating room ready to churn out individualized implants designed from patient data at a moment’s notice is still a long way off. Regulatory hurdles remain, clinical studies are still in progress, and building buy-in from hospitals will take time. What we’re seeing today, however, are the innovators taking the first steps.

Kumovis Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Kumovis Rank

  • When was Kumovis founded?

    Kumovis was founded in 2017.

  • Where is Kumovis's headquarters?

    Kumovis's headquarters is located at Trimburgstrasse 2, Munich.

  • What is Kumovis's latest funding round?

    Kumovis's latest funding round is Acquired.

  • How much did Kumovis raise?

    Kumovis raised a total of $3.97M.

  • Who are the investors of Kumovis?

    Investors of Kumovis include 3D Systems, High-Tech Grunderfonds, Solvay Ventures, Philips Health Technology Ventures, Renolit and 3 more.

  • Who are Kumovis's competitors?

    Competitors of Kumovis include Stratasys, Onkos Surgical, restor3d, Neo, Centinel Spine, Vertos Medical, Markforged, Formlabs, Nexa3D, Cyfuse Biomedical and 22 more.

You May Also Like

Carbon Logo
Carbon

Carbon is a 3D printing company that works at the intersection of hardware, software, and molecular science. Its SpeedCell is a system of connected manufacturing unit operations that enables repeatable production of end-use parts with industrial-grade materials. It caters mainly to the automotive, consumer, industrial life sciences, and dental industries. The company was founded in 2013 and is based in Redwood City, California.

Onkos Surgical Logo
Onkos Surgical

Onkos Surgical is a specialty medtech company dedicated to advancing surgical oncology solutions. Onkos Surgical is developing products for both hard and soft-tissue applications. The company was founded in 2015 and is based in Parsippany, New Jersey.

P
Paragon28

Paragon28 creates new and improved solutions to the challenges faced by foot and ankle specialists.

Formlabs Logo
Formlabs

Formlabs designs and manufactures 3D printing systems for engineers, designers, and artists.

C
Cyfuse Biomedical

Cyfuse Biomedical is focused on the development, manufacturing, and sales of regenerative medicine-related products. The company aims to contribute to the medical fields of regenerative medicine and drug discovery by generating steric tissues and organs. The company has developed Regenova, a 3D bioprinter.

V
Vertos Medical

Vertos Medical is a medical device company committed to developing minimally invasive treatments for lumbar spinal stenosis (LSS). Its proprietary technologies include mild®, which offers a safe, outpatient, minimally invasive, fluoroscopically guided therapeutic LSS treatment that requires no general anesthesia, no implants, and no stitches. LSS is primarily a degenerative, age-related narrowing of the lower spinal canal that causes symptoms of pain and numbness in the lower back, legs, or buttocks. mild® treats this condition by restoring space in the spinal canal using specialized mild® devices to remove hypertrophic ligamentum flavum through a 5.1 mm treatment portal. Clinical trials show that mild® can help LSS patients stand longer and walk farther with less pain1, and no major device-related complications have been reported.2

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.